| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $4,440,616 ) |
| | 2025 | 2025 | AUTONOMOUS THERAPEUTICS INC | 11808 AUTH LN | SILVER SPRING | MD | 20902-1643 | MONTGOMERY | USA | R01AI180651 | Targeting Feedback Circuitry for Antiviral Therapy | 003 | 2 | NIH | 3/25/2025 | $794,033 |
| | 2025 | 2025 | AUTONOMOUS THERAPEUTICS INC | 11808 AUTH LN | SILVER SPRING | MD | 20902-1643 | MONTGOMERY | USA | R01AI180651 | Targeting Feedback Circuitry for Antiviral Therapy | 001 | 2 | NIH | 12/4/2024 | $1,510,374 |
| | 2025 | 2024 | AUTONOMOUS THERAPEUTICS INC | 11808 AUTH LN | SILVER SPRING | MD | 20902-1643 | MONTGOMERY | USA | R37AI109593 | Modulating Stochastic Gene Expression for Cell-fate Control and Therapeutics | 004 | 10 | NIH | 3/26/2025 | $11,230 |
| | 2025 | 2024 | AUTONOMOUS THERAPEUTICS INC | 11808 AUTH LN | SILVER SPRING | MD | 20902-1643 | MONTGOMERY | USA | R37AI109593 | Modulating Stochastic Gene Expression for Cell-fate Control and Therapeutics | 001 | 10 | NIH | 12/4/2024 | $905,866 |
| | 2025 | 2024 | AUTONOMOUS THERAPEUTICS INC | 11808 AUTH LN | SILVER SPRING | MD | 20902-1643 | MONTGOMERY | USA | DP1DA051144 | A Gene Drive Therapy for HIV: Single-Administration Intervention for High-RiskGroups | 005 | 6 | NIH | 3/25/2025 | $36,157 |
| | 2025 | 2024 | AUTONOMOUS THERAPEUTICS INC | 11808 AUTH LN | SILVER SPRING | MD | 20902-1643 | MONTGOMERY | USA | DP1DA051144 | A Gene Drive Therapy for HIV: Single-Administration Intervention for High-RiskGroups | 005 | 6 | NIH | 3/25/2025 | $410,773 |
| | 2025 | 2024 | AUTONOMOUS THERAPEUTICS INC | 11808 AUTH LN | SILVER SPRING | MD | 20902-1643 | MONTGOMERY | USA | R37AI109593 | Modulating Stochastic Gene Expression for Cell-fate Control and Therapeutics | 004 | 10 | NIH | 3/26/2025 | $55,343 |
| | 2025 | 2024 | AUTONOMOUS THERAPEUTICS INC | 11808 AUTH LN | SILVER SPRING | MD | 20902-1643 | MONTGOMERY | USA | DP1DA051144 | A Gene Drive Therapy for HIV: Single-Administration Intervention for High-RiskGroups | 001 | 6 | NIH | 12/20/2024 | $716,839 |
|
| Issue Date FY: 2024 ( Subtotal = $273,644 ) |
| | 2024 | 2024 | AUTONOMOUS THERAPEUTICS INC | 11808 AUTH LN | SILVER SPRING | MD | 20902-1643 | MONTGOMERY | USA | R43AI184267 | Synthetic RNA sensors to enable high-throughput, quantitative screens for broad-spectrum antivirals | 000 | 1 | NIH | 5/8/2024 | $273,644 |
|
|
